Luis Jáuregui

Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis

Steven M. Opal, Pierre‐François Laterre, Bruno François et al. · JAMA · 2013 · 770 citations · Full text

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial*

Steven M. Opal, Pierre‐François Laterre, Edward Abraham et al. · Critical Care Medicine · 2004 · 145 citations

Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum

J Schwartz, Luis Jáuregui, John Lettieri et al. · Antimicrobial Agents and Chemotherapy · 1988 · 96 citations · Full text

Therapeutic Drug Monitoring, Theophylline Concentrations, Antibiotics +10

Use of single sample clearance estimates of cytochrome P450 substrates to characterize human hepatic CYP status<i>in vivo</i>

K Bachmann, Luis Jáuregui · Xenobiotica · 1993 · 49 citations

Osteomyelitis, pericarditis, mediastinitis, and vasculitis due to mycobacterium chelonei.

Luis Jáuregui, Agustin Arbulu, Fred Wilson · Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) · 1977 · 44 citations